GRALNasdaqServices-Medical LaboratoriesFiscal year ends December 31
GRAIL, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$122.42+4.61 (+3.91%)
Close on Oct 19, 2026
- Market cap
- $5.28B
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$44.42 (+56.95%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
GRAIL, Inc. grew revenue 23.1% to $165.26M over the twelve months to Jun 30, 2026. Free cash flow was -$296.16M.
Revenue
$165.26M
+23.1% vs. a year earlier
Operating income
-$559.25M
TTM Q2 2026
Free cash flow
-$296.16M
TTM Q2 2026
EPS, diluted
-$9.74
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $5.28B
- P/E ratio
- –
- Price to sales
- 31.94
- Price to book
- 2.08
- Dividend yield
- –
- Free cash flow yield
- -5.61%
Fundamentals
- Revenue
- $165.26M
- Net income
- -$391.59M
- EPS, diluted
- -$9.74
- Free cash flow
- -$296.16M
- Book value per share
- $58.98
- Diluted shares
- 43M
Five years at a glance
Fiscal years 2021 to 2025 and trailing twelve months, USD
Revenue
$165.26M+23.1% YoY
Operating income
-$559.25M
Net income
-$391.59M
EPS, diluted
-$9.74
Free cash flow
-$296.16M
Reported periodTrailing twelve months